REG - Transense Technlgy - Grant of share options to Director and employees

Transense TechnologiesAnnouncement

27/03/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230327:nRSa2274Ua&default-theme=true

RNS Number : 2274U  Transense Technologies PLC  27 March 2023

Transense Technologies plc

("Transense", or "the Company")

 

Grant of share options to Director and employees

 

Transense Technologies plc (AIM: TRT), the provider of specialist sensor
systems, announces that it has today granted 200,000 options to acquire
ordinary shares in the Company to employees and a Director (the "Options").

In accordance with the Company's share scheme, the Options have an exercise
price at nominal value of 10 pence per share and can be exercised after three
years until the tenth anniversary of the grant.  Two thirds of the options
are only exercisable if the Company's share price exceeds 150 pence per share
for ten consecutive trading days at any time. The remaining one third are only
exercisable in full if the share price exceeds 200 pence per share for ten
consecutive trading days at any time, with none of this tranche being
exercisable if the share price has not exceeded 150 pence per share for ten
consecutive trading days and a pro-rata amount will be exercisable between
these two share price targets.

Since the last audited financial statements of the Company, for the year ended
30 June 2022, a total of 332,000 options have lapsed. Accordingly, following
this announcement there are 1,462,500 unexercised share options over ordinary
shares in issue, representing approximately 8.90% of the current issued share
capital of the Company.

Included in the above grant of options are 100,000 options granted to Ryan
Maughan, a director of the Company, taking his total unexercised share options
to 150,000.

For further information please visit www.transense.com or contact:

 Transense Technologies plc                                   Via Walbrook PR

 Nigel Rogers (Executive Chairman)

 Melvyn Segal (CFO)
 Allenby Capital (Nominated Adviser and Broker)               Tel: +44 (0)20 3328 5656

 Jeremy Porter/George Payne (Corporate Finance)

 Tony Quirke/Jos Pinnington (Sales & Corporate Broking)
 Walbrook PR                                                  Tel: +44 (0)20 7933 8780

 Tom Cooper/Nick Rome / Joseph Walker                         Transense@walbrookpr.com

 

Notes to Editors:

Transense is a developer of specialist wireless sensor systems used to enable
real-time data gathering and monitoring.  Products include the patent
protected Surface Acoustic Wave (SAW) sensor technology, used to improve
equipment power, performance, reliability and efficiency; iTrack, Transense's
Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the
world's largest tyre producer, under a ten-year deal in June 2020; and a range
of intelligent tyre monitoring equipment under the Translogik brand. Target
sectors include aerospace, automotive (high performance and off-road) and
complex machine control.

The Group's strategy is to maximise shareholder value through the delivery of
sustained revenue growth from all three principal technologies - SAW, iTrack
and Translogik probes - through leveraging excellence in innovation, know-how
in commercialising technologies, industry partnerships and exposure to global
growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on
AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.
www.transense.com

For further information please contact transense@walbrookpr.com.

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Ryan Maughan

 2    Reason for the notification

 a)   Position/status                                              Business Development Director

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Transense Technologies plc

 b)   LEI                                                          2138005N52J6KKQ3EY67

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Options over Ordinary shares of 10 pence each

      Identification code                                          GB00BDHDTH21

 b)   Nature of the transaction                                    Grant of options

 c)   Price and volume                                             Exercise Price(s) 10p

                                                                   Volume(s) 100,000
 d)   Aggregated information

      - Aggregated volume                                          As above

      - Price

 e)   Date of the transaction                                      27 March 2023

 f)   Place of the transaction                                     Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEBXGDXUUDDGXU